Nancy Wexler, PhD, received the Benjamin Franklin Medal in Life Science for her discovery of the gene for Huntington’s Disease
In 2007, Nancy Wexler, PhD, received the Benjamin Franklin Medal in Life Science for her discovery of the…
In 2007, Nancy Wexler, PhD, received the Benjamin Franklin Medal in Life Science for her discovery of the…
In 2007, Dr. Jordan Tang, led a team of scientists at Oklahoma Medical Research Foundation (OMRF) that identified…
In 2007, The Oregon Translational Research and Drug Discovery Institute (OTRADI) at Oregon State University was established by…
In 2007, the Vanderbilt Center for Neuroscience Drug Discovery was established, combining the expertise of four groups of…
In 2007, The St. Jude LIFE study on the long-term effects of cancer and its treatment began. This…
In 2007, Texans voted to create the Cancer Prevention & Research Institute of Texas (CPRIT) and to invest…
In 2007, Texas Biomed geneticists announced their discovery that a particular gene, VNN1, plays a major role in…
In 2007, the Center for Clinical and Translational Research (CCTR) was founded at Virginia Commonwealth University to enhance…
In 2007, R. Paul Robertson, M.D., at the Pacific Northwest Research Institute, received two grants totaling $3,173,400 from…
In 2007, Cocrystal Discovery, now known as Cocrystal Pharma, was founded in Bothell as a pharmaceutical company with…
On Apr. 25, 2007, Jubilant Organosys, Ltd. announced it had acquired Spokane-based Hollister-Stier for $122.5 million. The plant…
On Dec. 14, 2006, the U.S. Centers for Disease Control and Prevention (CDC) reported a multi-state outbreak of…
On Nov. 27, 2006, the Animal Enterprise Terrorism Act (AETA) was officially signed into law by President George…
On Nov. 20, 2006, the Genome Sequencing Center at Washington University School of Medicine in St. Louis announced…
On Nov. 16, 2006, the U.S. Food and Drug Administration (FDA) approved Genentech’s trastuzumab (Herceptin) for use with…
On Oct. 19, 2006, the U.S. Food and Drug Administration (FDA) granted Glivec® (imatinib) has received US regulatory…
On Oct. 19, 2006, the National Cancer Institute part of the National Institutes of Health, announced it had…
On Oct. 18, 2006, ICOS announced it had signed an agreement to be acquired by Eli Lilly and…
On Oct. 18, 2006, Trubion Pharmaceutical completed its IPO of 4,000,000 shares of common stock at $13.00 per…
On Oct. 16, 2006, the National Cancer Institute (NCI) and the National Human Genome Research Institute (NHGRI), both…
On Oct. 10, 2006, Yale Cancer Center was awarded a SPORE (Specialized Programs of Research Excellence) grant for…
On Oct. 5, 2006, the Foundation for the National Institutes of Health, National Institutes of Health, Food and…
On Oct 2, 2006, National Cancer Institute researchers have linked specific genetic mutations to defects in cells that…
On Sept. 28, 2006, the Virginia Bioinformatics Institute (VBI) at Virginia Tech announced that it will officially open…
On Sept. 27, 2006, the National Cancer Institute announced funding for a major component of its $104 million,…
On Sept. 26, 2006, the Allen Institute for Brain Science announced the completion of the groundbreaking Allen Brain…
On Sept. 15, 2006, the Oklahoma Medical Research Foundation (OMRF) celebrated it’s 60th anniversary. More than 600 people…
On Sept. 8, 2006, BD (Becton, Dickinson) announced an agreement to acquire the 93.5% of the outstanding shares…
On Sept. 6, 2006, a report from the nation’s leading cancer organizations found that Americans’ risk of dying…
On Sept. 1, 2006, National Cancer Institute (NCI) researchers developed a new model for estimating the 5-year risk…